Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure
Breast Neoplasms
About this trial
This is an interventional prevention trial for Breast Neoplasms focused on measuring Seroma Formation, Axillary Lymph Node Dissection, Breast cancer, Early Vacuum Assisted Closure
Eligibility Criteria
Inclusion Criteria:
- Written informed consent
- patients diagnosed with breast cancer, receiving modified radical mastectomy and axillary dissection;
- Body Mass Index ≥28;
- drainage volume within the first 48 hours is more than 200 mL.
Exclusion Criteria:
- Subjects with coagulation disorders shown by exceeding the normal range of any of following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT), fibrinogen level, or thrombocytes.
- Subjects having previously had axillary surgery,
- Subjects having undergone irradiation therapy to the axillary tissue
- Subjects having ever received chemotherapy before the surgery,
- Subjects with known hypersensitivity to components of the surgical sticky membrane
Sites / Locations
- Changhai Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Axillary dissection
vacuum assisted closure
Axillary dissection is a surgical procedure that incises (opens) the armpit (axilla or axillary) to identify, examine, or remove lymph nodes (small glands, part of the lymphatic system, which filters cellular fluids).
Vacuum assisted closure (also called vacuum therapy, vacuum sealing or topical negative pressure therapy) is a sophisticated development of a standard surgical procedure, the use of vacuum assisted drainage to remove blood or serous fluid from a wound or operation site.